home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Virus May Offer A New Avenue For Cancer Therapy

 
  August, 31 2001 18:58
your information resource in human molecular genetics
 
     
VIRUS TAKES ADVANTAGE OF CANCER

A virus that exploits a gene defect common to cancer cells and selectively kills them may offer a new avenue for therapy, suggest researchers in this week’s Nature (Vol. 412, No. 6850, 30 Aug 2001).

The gene p53 is mutated in about half of all human cancers (an event directly implicated in tumour progression) so a way of killing such cells offers the attractive possibility of treating multiple cancer types with one drug. The human adeno-associated virus (AAV) selectively induces cell death in p53-defective cells, Peter Beard and his colleagues of the Swiss Institute for Cancer Research (ISREC) in Epalinges, Switzerland, have now discovered. Cells retaining their copy of p53 instead halt cell division.

Even AAVs engineered to lack all genes and containing only hairpin-looped DNA ends cause cell death, suggesting that the viral DNA structure mimics DNA damage in the cell. Cells have very sensitive sensors for DNA damage that can activate repair mechanisms or drive them to suicide to prevent mutation accumulation and hence potential oncogenic transformation. Tumours in mice were also reduced by injection of the virus, the team found.

Continued research into strategies to exploit p53 should eventually lead to one that bears fruit — "each of which has the potential to benefit millions," say Bert Vogelstein and Kenneth Kinzler at the Howard Hughes Medical Institute and Johns Hopkins Oncology Center in Baltimore, Maryland, in an accompanying News and Views article.

CONTACT:

Peter Beard
tel +41 21 692 5921
e-mail peter.beard@isrec.unil.ch

Bert Vogelstein
tel +1 410 955 8877
e-mail vogelbe@welch.jhu.edu

Kenneth Kinzler
tel +1 410 955 2928
e-mail kinzlke@welchlink.welch.jhu.edu

(C) Nature press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.